title: Tenth International Foamy Virus Conference 2014--achievements and perspectives.
abstract: For the past two decades, scientists from around the world, working on different aspects of foamy virus (FV) research, have gathered in different research institutions almost every two years to present their recent results in formal talks, to discuss their ongoing studies informally, and to initiate fruitful collaborations. In this report we review the 2014 anniversary conference to share the meeting summary with the virology community and hope to arouse interest by other researchers to join this exciting field. The topics covered included epidemiology, virus molecular biology, and immunology of FV infection in non-human primates, cattle, and humans with zoonotic FV infections, as well as recent findings on endogenous FVs. Several topics focused on virus replication and interactions between viral and cellular proteins. Use of FV in biomedical research was highlighted with presentations on using FV vectors for gene therapy and FV proteins as scaffold for vaccine antigen presentation. On behalf of the FV community, this report also includes a short tribute to commemorate Prof. Axel Rethwilm, one of the leading experts in the field of retrovirology and foamy viruses, who passed away 29 July 2014.
authors.affiliation: Department of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. magdalena.materniak@piwet.pulawy.pl.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Materniak
authors.affiliation: Department of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. kubip@piwet.pulawy.pl.
authors.forename: Piotr
authors.initials: P
authors.lastname: Kubiś
authors.affiliation: Department of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland.
authors.forename: Marzena
authors.initials: M
authors.lastname: Rola-Łuszczak
authors.affiliation: Laboratory of Retroviruses, Division of Viral Products, OVRR, CBER, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. arifa.khan@fda.hhs.gov.
authors.forename: Arifa S
authors.initials: AS
authors.lastname: Khan
authors.affiliation: Unité d'épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. florence.buseyne@pasteur.fr.
authors.forename: Florence
authors.initials: F
authors.lastname: Buseyne
authors.affiliation: Institute of Virology, Medical Faculty "Carl Gustav Carus", Technische Universität Dresden, 01307 Dresden, Germany. Dirk.Lindemann@tu-dresden.de.
authors.forename: Dirk
authors.initials: D
authors.lastname: Lindemann
authors.affiliation: Department of Genome Modifications and Carcinogenesis, German Cancer Research Center, 69121 Heidelberg, Germany. m.loechelt@dkfz.de.
authors.forename: Martin
authors.initials: M
authors.lastname: Löchelt
authors.affiliation: Department of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. jkuzmak@piwet.pulawy.pl.
authors.forename: Jacek
authors.initials: J
authors.lastname: Kuźmak
mesh_terms: D000818:Animals; D035843:Biomedical Research / Q000639:trends; D002417:Cattle; D006801:Humans; D011323:Primates; D012192:Retroviridae Infections / Q000453:epidemiology / Q000276:immunology / Q000662:veterinary* / Q000821:virology*; D016092:Spumavirus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity / Q000502:physiology*
references.citation: Retrovirology. 2011;8(1):6
references.pmid: 21255441
references.citation: Virol J. 2011;8:198
references.pmid: 21529378
references.citation: Vaccine. 2012 Apr 19;30(19):2956-62
references.pmid: 22387218
references.citation: J Virol. 2012 Jul;86(14):7696-8
references.pmid: 22573860
references.citation: PLoS Pathog. 2012;8(6):e1002790
references.pmid: 22761578
references.citation: Virology. 2013 Jan 5;435(1):187-99
references.pmid: 23217627
references.citation: Mol Ther. 2013 May;21(5):964-72
references.pmid: 23531552
references.citation: Viruses. 2013 Jun;5(6):1414-30
references.pmid: 23744104
references.citation: Viruses. 2013 Oct;5(10):2349-74
references.pmid: 24072062
references.citation: PLoS One. 2013;8(10):e77072
references.pmid: 24116202
references.citation: J Virol. 2014 May;88(9):4679-86
references.pmid: 24522910
references.citation: MBio. 2014;5(2):e00074
references.pmid: 24713319
references.citation: PLoS One. 2014;9(5):e97931
references.pmid: 24835242
references.citation: Blood. 2014 Jun 5;123(23):3578-84
references.pmid: 24642749
references.citation: Retrovirology. 2014;11:61
references.pmid: 25091111
references.citation: J Gene Med. 2014 Jul-Aug;16(7-8):166-78
references.pmid: 25044583
references.citation: J Virol. 2014 Nov;88(22):13429-35
references.pmid: 25210185
references.citation: J Am Vet Med Assoc. 2000 Nov 15;217(10):1475-9
references.pmid: 11128537
references.citation: Trends Microbiol. 2000 Jun;8(6):284-9
references.pmid: 10838587
references.citation: J Virol. 2000 May;74(9):4064-73
references.pmid: 10756018
references.citation: J Vet Med B Infect Dis Vet Public Health. 2003 Nov;50(9):417-23
references.pmid: 14633194
references.citation: J Immunol Methods. 1997 Aug 22;207(1):69-77
references.pmid: 9328588
references.citation: Proc Natl Acad Sci U S A. 2005 May 31;102(22):7982-7
references.pmid: 15911774
references.citation: J Virol. 2005 Jul;79(14):8724-31
references.pmid: 15994766
references.citation: Virology. 2007 Jul 20;364(1):123-31
references.pmid: 17408715
references.citation: J Virol. 2008 Jun;82(11):5429-39
references.pmid: 18367529
references.citation: Genome Biol. 2008;9(3):R48
references.pmid: 18315870
references.citation: Virology. 2009 Feb 5;384(1):7-11
references.pmid: 19070882